Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease

R Nakashima, Y Hosono, T Mimori - Lupus, 2016 - journals.sagepub.com
Anti-aminoacyl-tRNA synthetase (ARS) and anti-melanoma differentiation-associated gene
5 (MDA5) antibodies are closely associated with interstitial lung disease in polymyositis and …

Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of …

N Yoshida, M Okamoto, S Kaieda, K Fujimoto… - Respiratory …, 2017 - Elsevier
Background We attempted to clarify whether the presence of anti-aminoacyl-transfer RNA
synthetase antibody (anti-ARS Ab) or anti-melanoma differentiation-associated gene 5 …

Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis

J Temmoku, S Sato, Y Fujita, T Asano, E Suzuki… - Medicine, 2019 - journals.lww.com
Myositis-specific autoantibodies, such as anti-melanoma differentiation associated gene 5
(MDA5) and anti-anti-amino acyl-tRNA synthetases (ARS) antibodies, are associated with …

Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control …

H Hozumi, N Enomoto, M Kono, T Fujisawa, N Inui… - PLoS …, 2015 - journals.plos.org
Background In polymyositis/dermatomyositis (PM/DM), anti-aminoacyl-tRNA synthetase
(ARS) antibodies are closely associated with interstitial lung disease (ILD), a frequent …

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

H Yoshifuji, T Fujii, S Kobayashi, Y Imura, Y Fujita… - …, 2006 - Taylor & Francis
In the treatment of polymyositis and dermatomyositis (PM/DM), the complication of interstitial
lung disease (ILD) is an important prognostic factor. It has been reported that autoantibodies …

[HTML][HTML] The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies

K Tanizawa, T Handa, R Nakashima, T Kubo… - Respiratory …, 2017 - Elsevier
Rationale Anti-aminoacyl transfer RNA synthetase antibodies (anti-ARS) are a group of
myositis-specific autoantibodies that are detected in the sera of patients with polymyositis …

Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA …

K Isoda, T Kotani, T Takeuchi, T Kiboshi, K Hata… - Rheumatology …, 2017 - Springer
The aim of this study was to investigate long-term prognosis and relapse of dermatomyositis
complicated with interstitial pneumonia (DMIP) according to anti-aminoacyl tRNA synthetase …

Clinical significance of myositis-specific autoantibodies

R Nakashima - Immunological medicine, 2018 - Taylor & Francis
To date, increasing numbers of myositis-specific autoantibodies (MSAs) have been reported
and their clinical significance has been elucidated. Anti-aminoacyl-tRNA synthetase (ARS) …

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of …

T Gono, Y Kawaguchi, T Satoh, M Kuwana… - …, 2010 - academic.oup.com
Objective. The aim of this study is to evaluate the clinical manifestation and prognostic
factors of anti-melanoma differentiation-associated gene 5 (MDA5) antibody-associated …

Interstitial lung disease with autoantibodies againstaminoacyl-tRNA synthetases in the absence of clinically apparent myositis

AW Friedman, IN Targoff, FC Arnett - Seminars in arthritis and rheumatism, 1996 - Elsevier
Autoantibodies against aminoacyl-tRNA synthetases (antisynthetases) havebeen found to
be highly specific for polymyositis and dermatomyositis and to correlate strongly with …